A study, published in Infection Control & Hospital Epidemiology, examined the factors associated with first Clostridium difficile infection that predict the use of fecal microbiota transplantation for ...

Clostridium difficile infections elevate the risks for colectomy, mortality and postoperative complications after a colectomy for patients with ulcerative colitis, according to NEJM Journal Watch.

Two gastroenterologists spoke with Becker’s to discuss research challenges, advice for early-career physicians and more. Paul Feuerstadt, MD, is a practicing gastroenterologist at the ...

Twenty-four percent of healthcare workers carried spores of Clostridium difficile on their hands even after following proper hand hygiene protocol after patient contact, according to a study published ...

Compared with azithromycin, doxycycline was associated with reduced Clostridioides difficile infection (CDI) among hospitalized patients with community-acquired pneumonia (CAP), a retrospective cohort ...

Bethesda, MD (Feb. 21, 2024) — In the first comprehensive evidence-based guideline on the use of fecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological ...

C. diff is "a big concern," but limited Medicare and Medicaid reimbursements strain budgets, says Nancy Foster, the American Hospital Association's vice president for quality and patient safety.

Frozen fecal transplantation is effective at providing relief to Clostridium difficile (C. diff) patients, according to a new study co-authored by University of Guelph researchers. The study found ...

A new study published today in the American Journal of Infection Control (AJIC) reveals that the use of doxycycline may help protect against Clostridioides difficile (C. diff) infection for some ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

Christian John Lillis, cofounder and executive director of the Peggy Lillis Foundation for C difficile Education & Advocacy, explained how FDA-approved microbiome-based therapeutics help to treat and ...

A new study on Clostridioides difficile infections finds that choosing an alternative antibiotic for high-risk patients with pneumonia can reduce infection risk. C. diff infections can be deadly, and ...